To enhance the robustness and validity of these conclusions, future studies with larger cohorts of patients will be required to determine if the variants detected in the present study may be potential candidates for prospectively identifying an accurate prognosis for chronic or indolent patients with MYCN non-amplified and MYCN amplified neuroblastoma. Here, MYCN is linked to neuroblastoma.